Exploiting angiogenesis.
D043925:Angiogenesis Inducing Agents / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002464:Cell Migration Inhibition; D003510:Cyclohexanes; D006801:Humans; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D012717:Sesquiterpenes / Q000494:pharmacology / Q000627:therapeutic use
D043925:Angiogenesis Inducing Agents; D003510:Cyclohexanes; D012717:Sesquiterpenes; D000077609:O-(Chloroacetylcarbamoyl)fumagillol